IRCT20160310026998N7招募中未知
Comparison of the effect of deferasirox and deferiprone combination and defroxamine/deferiprone regimen among patients with beta-thalassemia
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 54
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12 years 至 no limit（—）
- 性别
- All
入选标准
- •ß thalassemia patients who have continuous blood transfusions receiving deferoxamine with deferiprone.
排除标准
- •Patients who changes their chelator during the study.
- •Patients who changes thier blood transfusion pattern during the study
- •Patients with liver complications (rise of aminotransferase >5 times of baseline)
- •Pregnant women
- •Patients with renal insufficiency with a creatinine clearance (GFR) of less than 30 ml / min.
- •patients with renal adverese effect of chelating agent (rise serum creatinine>2 time of baseline orproteinuria)
研究者
相似试验
已完成
3 期
Compare the efficacy of combination therapy of Deferasirox and Deferiprone in reducing iron load in patients with transfusion-Dependent ß-Thalassemia.transfusion-Dependent ß-Thalassemia.Beta thalassemiaIRCT20190106042262N1Esfahan University of Medical Sciences108
已完成
2 期
Effect of Osveral on iron overload in beta thalassemia major patients.beta thalassemia.beta thalassemiaIRCT2015102524679N2Investigator69
已完成
不适用
?Exir research project of desferoxamin with brand name of Deferoxirthalassemia major.Cooley anaemia Severe beta thalassaemia Thalassaemia: intermedia majorIRCT2015012620818N1exir pharmacutical company100
已完成
Unknown
Comparison of Deferazirox and Deferoxamine on Serum Ferritin Levels Changes in Major Beta Thalassemia PatientsIRCT20190817044550N4Birjand University of Medical Sciences45
进行中（未招募）
不适用
Phase I study to examine the effect of deferasirox on renal hemodynamics in β-thalassemia patients with transfusional iron overload - NDMedDRA version: 6.1Level: HLGTClassification code 10022958thalassemiaEUCTR2006-006838-17-ITOVARTIS FARMA8